Back to companies

G9pharma co., LTD

078650KRKRX

지나인제약

Revenue
₩25.0mn
FY2023
Operating income
-₩948.9mn
FY2023
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)